were incubated with 50 ng/ml VEGF or control for 2 (C) Inhibition of endogenous NOS increases vWF release. HAEC were pretreated with L-NAME for 16 hr, incubated with thrombin for hr, and then stimulated with thrombin. VEGF treatment 1 hr, and vWF released from cells was measured as above (n ϭ 2 Ϯ decreases thrombin stimulated vWF release ( Figure 1D ). SD, *p Ͻ 0.06 versus thrombin; **p ϭ 0.03 versus thrombin).
L-NAME 1 mM blocks the effects of VEGF treatment, (D) Activation of endogenous NOS decreases vWF release. HAEC
implying that NO mediates VEGF inhibition of exocytosis were pretreated with media or 1 mM L-NAME for 16 hr, stimulated ( Figure 1D ). Since L-NAME inhibition of NOS increases with 50 ng/ml VEGF for 2 hr, and then incubated with thrombin. The exocytosis and since VEGF activation of NOS decreases amount of released vWF was measured as above (n ϭ 3 Ϯ SD, *p Ͻ exocytosis, taken together, these data suggest that en-
versus control).
dogenous NO regulates endothelial cell exocytosis.
SNARE Molecules Regulate Weibel-Palade molecules regulate exocytosis of vesicles and granules

Body Exocytosis
from other cells, we reasoned that they might also reguThe molecular machinery that regulates Weibel-Palade body exocytosis is unknown. However, since SNARE late endothelial cell exocytosis of Weibel-Palade bodies as well. We first determined the expression of SNARE 25% ( Figure 2C ). Antibody to ␣-SNAP also inhibits vWF release. molecules in endothelial cells, using brain extracts as a control. HAEC and human brain extracts were immuOur second approach to demonstrating NSF regulation of Weibel-Palade body exocytosis involved peptide noblotted with antibodies to SNARE molecules. HAEC express VAMP-3, syntaxin-2 and syntaxin-4, and SNAPinhibition of NSF. We designed a peptide inhibitor of NSF that crosses cell membranes. This peptide, designated 23 ( Figure 4A ). To determine the importance of individual cysteine residues in NSF functions, we made nine indiand SNAP-23. ATP or ATP-␥S was added, the mixture was precipitated with glutathione-sepharose beads, vidual NSF mutants, each lacking one of the nine cysteine residues, and then compared the activity of wildand precipitated proteins were fractionated by SDS-PAGE and immunoblotted with antibody to the NSF tag. type NSF to mutant NSF. We first determined which cysteine residues mediate NSF with ␣-SNAP interacts with GST-syntaxin-4 (Figure 3C) . ATP decreases the interaction of NSF with GST-NSF ATPase activity. We measured the ATPase activity of wild-type NSF and of each NSF mutant. Mutation of syntaxin-4; ATP also decreases the coprecipitation of VAMP-3 and SNAP-23 along with GST-syntaxin-4, precysteine residues 21, 91, 264, and 334 partially decrease NSF ATPase activity ( Figure 4B , white bars). sumably by NSF disassembly of the SNARE complex. As expected, ATP-␥S blocks NSF disassembly activity.
We next determined which cysteine residues mediate NSF interactions with SNARE molecules. We repeated However, NO blocks NSF disassembly of the SNARE complex, even in the presence of ATP ( Figure 3C ). Furthe pull-down assay with wild-type and mutant NSF. NSF and ␣-SNAP were incubated with GST-SNARE futhermore, DTT restores the disassembly activity of NSF pretreated with NO, suggesting that NO inhibition of sion polypeptides in the presence of ATP or ATP-␥S, and the mixture was precipitated with glutathione-seph-NSF disassembly is reversible. Finally, NO inhibits NSF disassociation from GST-syntaxin-4 in a dose-depenarose beads, and finally, immunoblotted with antibody to the NSF tag. Wild-type NSF interacts with GSTdent manner ( Figure 3D) .
(The low level of interaction between NSF and SNAREs SNAREs in the presence of ATP-␥S and disassembles GST-SNAREs in the presence of ATP ( Figure 4C ). Mutain the absence of adding additional ATP to the reaction mixture may be due to residual ATP in the storage buffer tion of cysteine residues 250 and 599 have no effect on NSF interaction and disassembly activity. Mutation of used to prepare recombinant NSF. Small amounts of ATP present in the reaction buffer may permit an interaccysteine residues 11, 21, 334, 568, and 582 block the ability of NSF to interact with GST-SNARE molecules. tion between NSF and SNAREs, while larger amounts enable NSF to disassemble the SNARE/␣-SNAP/NSF Mutation of cysteine residues 91 and 264 permit NSF to interact with the SNARE complex, but inhibit the abilcomplex.) ity of NSF to disassemble the GST-SNARE complex. These data suggest that one set of NSF cysteine resi-TAT-NSF Peptides Inhibit NSF ATPase Activity dues regulate NSF interactions with SNARE complexes and NSF Disassociation from SNAREs and another set of NSF cysteine residues regulate NSF NO and TAT-NSF peptides inhibit NSF by different disassembly of SNARE complexes. In particular, cysmechanisms. NO inhibits NSF disassembly activity but teine residues 91 and 264 appear to regulate NSF disasdoes not affect NSF ATPase activity, as shown above. sembly activity. In contrast, the TAT-NSF222 peptide inhibits both NSF ATPase activity ( Figure 3E ) and also NSF disassembly activity ( Figure 3F) . Thus, the mechanisms by which NO NSF Cysteine Residue Targets of NO and TAT-NSF peptides inhibit NSF are different: both We next used these NSF cysteine mutants to explore inhibit NSF disassembly activity, but only TAT-NSF pepwhich cysteine residues of NSF are targets of NO. We tides inhibit NSF ATPase activity as well. Since NO readded NO to wild-type and mutant NSF and measured versibly inhibits NSF disassembly activity without affectthe ATPase activity. NO does not affect ATPase activity ing its ATPase activity, we reasoned that NO targets of wild-type NSF and does not affect ATPase activity of NSF cysteine residues in regions of NSF that couple the any of the NSF mutants ( Figure 4B , black bars). energy of ATP hydrolysis to the mechanical energy of We then tested the effect of NO upon the disassembly disassembling the SNARE complex. activity of NSF mutants, using the pull-down assay. NO blocks the ability of wild-type NSF to disassemble the NO Inhibits Exocytosis by Inhibiting NSF SNARE complex in the presence of ATP ( Figure 4C ). To confirm that NSF is a primary physiological target of Mutation of cysteine residues 250 and 599 have no effect NO, we pretreated HAEC with 1 mM DEA-NONOate for on the ability of NO to inhibit NSF disassembly activity. 10 min to inhibit exocytosis, permeabilized the endotheThe effect of NO upon cysteine residues 11, 21, 334, lial cells as above, and then added recombinant NSF 568, and 582 cannot be ascertained, since mutation of 100 g/ml. HAEC were then resealed, stimulated with these residues abrogates NSF interaction with SNARE thrombin, and the amount of vWF released into the memolecules. Mutation of cysteine residues 91 and 264 dia was measured. As before, NO inhibits exocytosis blocks the ability of NSF to disassemble the SNARE ( Figure 3G ). However, exogenous recombinant NSF recomplex, and NO has no effect upon these mutants. stores the ability of NO treated HAEC to undergo exoWe next measured the number of cysteine residues cytosis ( Figure 3G ). In contrast, recombinant NSF prethat are nitrosylated by exogenous NO. We exposed treated with NO cannot restore the ability of NO treated recombinant NSF to increasing amounts of DEA-NONO-HAEC to undergo exocytosis ( Figure 3G We next identified the cysteine residues that are tardata suggest that NO nitrosylates cysteine residues 21, 91, and 264 of NSF. gets of NO by measuring the number of cysteines that are nitrosylated in wild-type and mutant NSF. DEA-NONOate was added to wild-type or mutant NSF that lack NO Nitrosylation of NSF Is Reversible Since NSF plays a general role in vesicle trafficking, specific cysteine residues, and the Saville reaction was used to measure the number of nitrosocysteine residues permanent inactivation of NSF would slow vesicular trafficking in general. However, local production of NO at per molecule of NSF. Mutation of cysteine residues 11, 250, 334, and 568 have no effect upon the nitrosocysthe plasma membrane and reversible nitrosylation of NSF could provide spatial regulation of NSF. In order to teine content ( Figure 4E ). However, mutation of cysteine residues 21, 91, or 264 decreases the nitrosocysteine measure how long NO inhibition of exocytosis lasts, we pretreated HAEC with the NO donor SNAP 100 M for content per NSF molecule by one ( Figure 4E ). These with NO, and 2-4 hr after treatment the level of nitrosylated NSF is similar to nontreated cells ( Figure 5B, top) . (In addition to the expected signal for NSF at 82 kDa, another band at approximately 70 kDa is observed.) Treatment with NO donors does not change the total amount of NSF for the first 4 hr, but total amounts of NSF increase 4-16 hr after NO treatment (Figure 5B, bottom) .
Taken together, these data show that within 2-4 hr of exposure to NO, nitrosylation of NSF, and inhibition of endothelial cell exocytosis is reversible.
NSF Is Nitrosylated and Regulates Exocytosis In Vivo
In order to test whether or not NO modifies NSF in vivo, we prepared cell lysates from HAEC treated with media or the NOS inhibitor L-NAME. Polypeptides in this lysate containing nitrosothiols were biotinylated, precipitated with avidin-agarose, and immunoblotted with antibody to NSF . NSF is nitrosylated in endothelial cells, and treatment of cells with increasing amounts of NOS inhibitor decreases NSF nitrosylation ( Figure 6A ). We next searched for nitrosylated NSF in mice. Polypeptides were prepared from spleens of wildtype and eNOS null mice as above. NSF is nitrosylated in wild-type mice expressing eNOS ( Figure 6B ). In contrast, NSF is not nitrosylated in eNOS-deficient mice. These data show that NO nitrosylates NSF in vivo.
To explore the physiological relevance of NSF regulation of Weibel-Palade body exocytosis, we measured the effect of the NSF inhibitory peptide upon the bleeding time in mice. Anesthetized mice were injected intra- 
NO Regulates Exocytosis In Vivo
We explored the physiological relevance of NO regulacreases after 1-2 hr; and 2-4 hr after NO treatment about 75% of Weibel-Palade body exocytosis is restored (Figtion of Weibel-Palade body exocytosis in two murine models. We measured the bleeding time in wild-type ure 5A). Thus, NO inhibition of exocytosis is reversible.
In order to examine directly the reversibility of NSF and eNOS-deficient mice. Lack of eNOS decreases the bleeding time in mice, which would be predicted if a nitrosylation, we pretreated endothelial cells with an NO donor as above and then harvested cell lysates at varilack of NO decreased NSF inhibition and permitted an increase in exocytosis of vWF ( Figure 6D ). We also meaous times after NO treatment. Cell lysates were immunoprecipitated with antibody to nitrosocysteine, fractionsured serum levels of vWF and soluble P-selectin in wild-type and eNOS-deficient mice. Serum levels of vWF ated by SDS-PAGE, and immunoblotted with antibody to NSF. Treatment with NO increases the level of nitroare higher in eNOS-deficient mice compared to wildtype mice (20 Ϯ 25 versus 11 Ϯ 14 mU/ml, although sylated NSF ( Figure 5B, top: Ϫ versus ϩ at 0 hr) . The level of nitrosylated NSF decreases 2 hr after treatment these differences are not significant for n ϭ 6). Serum The major finding of this study is that NO regulates exocytosis by nitrosylating NSF, thereby inhibiting NSF vWF, and an increase in platelet adherence to venule walls. We first showed that exogenous NO can inhibit disassembly activity. Inhibition of NOS increases endothelial release of vWF and increases platelet adherence histamine-induced exocytosis from HAEC ( Figure 7A ). We next employed intravital microscopy to explore the to the stimulated vessel wall. Although NSF was originally purified as a protein necessary for intercisternal effects of endogenous NO upon platelet rolling in vivo. Anesthetized mice were pretreated or not with L-NAME Golgi transport that was inhibited by NEM, our data suggests that NEM-Sensitive Factor is actually an NOand then transfused with calcein-AM labeled platelets. The mesentery was externalized, superfused with histaSensitive Factor. mine, and intravital microscopy was used to record interactions of fluorescently labeled platelets with mesenHow Does NO Inhibit NSF? NO regulates a wide variety of proteins by nitrosylation teric venules. Platelets were classified as adherent if they were transiently captured by the endothelium and of critical cysteine residues (Stamler, 1994; Stamler et al., 2001 Stamler et al., , 1992 . Our data suggest that NO regulates NSF then translocated in a stop-and-go fashion for a minimum of 2 s. Histamine rapidly induces platelet adhesion by covalently modifying cysteine residues of NSF C91 and C264. How might nitrosylation of C91 or C264 inhibit to the venule wall without aggregation, starting within 30 s and peaking 3 min after histamine treatment (Fig-NSF? Since NO inhibits NSF disassembly activity but does not affect NSF ATPase activity, NO may uncouple Importance of Cysteine Residues to NSF Function Our data emphasize the importance of cysteine residues the ability of NSF to convert the chemical energy of ATP hydrolysis into the mechanical energy necessary to the function of NSF. Specific cysteine residues play a role in ATP hydrolysis: mutation of C21, C91, C264, to separate the SNARE complex. NSF C91 is not adjacent to the N-terminal-D1 region linker, where its modifiand C334 reduces the ATPase activity of NSF by approximately 50% ( Figure 4B ). C264 is located within the cation might influence a conformational change of NSF. However, NSF C264 is located within the D1 domain Walker A motif of the D1 domain, and C334 is located three residues away from the Walker B motif of the D1 Walker A motif, which interacts with ATP, and it is possible that nitrosylation of C264 may affect the efficiency domain, so mutation of these residues may alter ATP binding or hydrolysis. Specific cysteine residues C11, by which ATP hydrolysis is converted into mechanical energy.
C21, C334, C568, and C582 are necessary for NSF to 
